Business
Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021
About this update from Bruker Corporation
[{"type":"text","content":"\n\nQ4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy\n\n\nQ4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy\n\n\nFY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy\n\n\nFY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy\n\n\nSolid organic revenue and non-GAAP EPS growth expected in FY 2022, with significant investments in Project Accelerate 2.0 initiatives, particularly in proteomics, spatial biology, semicon metrology and biopharma\n\n\n BILLERICA, Mass.--(BUSINESS WIRE)--\nBruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2021.\n\nFourth Quarter 2021 Financial Results\n\nBruker’s revenues for the fourth quarter of 2021 were $683.5 million, an increase of 8.9% compared to $627.5 million in the fourth quarter of 2020. In the fourth quarter of 2021, revenues increased 11.4% organically year-over-year. Growth from acquisitions was 0.3%, while foreign currency translation had a negative effect of 2.8%.\n\nFourth quarter 2021 Bruker Scientific Instruments (BSI) revenues of $629.2 million increased 9.5% year-over-year, with organic revenue growth of 11.8%. Fourth quarter 2021 Bruker Energy & Supercon Technologies (BEST) revenues of $57.8 million increased 5.7% year-over-year. Organic growth for BEST, net of intercompany eliminations, was 6.8%.\n\nFourth quarter 2021 GAAP operating income was $125.4 million, compared to $112.8 million in the fourth quarter of 2020, representing GAAP operating margins of 18.3%, and 18.0%, respectively. Non-GAAP operating income was $143.8 million in the fourth quarter of 2021, compared to $141.1 million in the fourth quarter of 2020. Bruker’s fourth quarter 2021 non-GAAP operating margin was 21.0%, a decline of 150 basis points (bps) compared to 22.5% in the fourth quarter of 2020. The decline was primarily due to the impact of ramping commercial investments in Project Accelerate 2.0, unfavorable revenue mix and supply chain challenges.\n\nFourth quarter 2021 GAAP diluted earnings per share (EPS) were $0.50, compared to $0.45 in the fourth quarter of 2020. Fourth quarter 2021 non-GAAP diluted EPS were $0.59, an increase of 1.7% compared to $0.58 in the fourth quarter of 2020.\n\nFiscal Year 2021 Financial Results\n\nFor fiscal year (FY) 2...